Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues.
D000596:Amino Acids / Q000494:pharmacology*; D000626:Aminopeptidases / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001224:Aspartic Acid / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002854:Chromatography, Paper; D004305:Dose-Response Relationship, Drug; D005998:Glycine / Q000494:pharmacology; D007668:Kidney / Q000201:enzymology / Q000502:physiology; D007930:Leucine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009392:Nephrectomy; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D012521:Sarcosine / Q000494:pharmacology; D013270:Stomach / Q000187:drug effects; D013329:Structure-Activity Relationship; D013552:Swine; D013997:Time Factors
D000596:Amino Acids; D010455:Peptides; D000804:Angiotensin II; D001224:Aspartic Acid; D000626:Aminopeptidases; D007930:Leucine; D005998:Glycine; D012521:Sarcosine